Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

VC Deals Analysis: How Four Bad Months Can Spoil The Barrel

Executive Summary

Another slow month for VC financing deals means total deal value for 2016 to date is now lagging behind that for the same period last year.

You may also be interested in...



VC Deals Analysis: One Big Beat After Long Lull

After a slow summer, September delivered a much welcomed boost to venture funding levels with the first nine-figure deal in four months.

VC DEAL ANALYSIS: Does Trend-Bucking August Signal Boom Year For Venture Financing?

August may be called the silly season for the news industry but for the medtech sector, last month saw serious money being raised privately by start-ups and growing SMEs.

Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?

Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.

Topics

Related Companies

UsernamePublicRestriction

Register

MT103809

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel